Neonatal Sepsis and Neutrophil Insufficiencies

REFERENCES

• Watson RS, Carcillo JA. Scope and epidemiology of pediatric sepsis. Pediatr Crit Care Med 2005; 6: S3–S5.
   PubMedGoogle Scholar
• Watson RS, Carcillo JA, Linde-Zwirble WT, The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003; 167:695–701.
   PubMed Web of Science ®Google Scholar
• Lawn JE, Cousens S, Zupan J, Lancet Neonatal Survival Steering Team. 4 million neonatal deaths: When? Where? Why? Lancet 2005; 365: 891–900.
   PubMed Web of Science ®Google Scholar
• Levy MM, Fink MP, Marshall JC, 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250–1256.
   PubMed Web of Science ®Google Scholar
• Bone RC, Balk RA, Cerra FB, Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644–1655.
   PubMed Web of Science ®Google Scholar
• Goldstein B, Giroir B, Randolph A, and International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6: 2–8.
   PubMedGoogle Scholar
• Chiesa C, Panero A, Osborn JF, Diagnosis of neonatal sepsis: A clinical and laboratory challenge. Clin Chem 2004; 50: 279–287.
   PubMed Web of Science ®Google Scholar
• Gerdes JS. Clinicopathologic approach to the diagnosis of neonatal sepsis. Clin Perinatol 1991; 18: 361–381.
   PubMed Web of Science ®Google Scholar
• Gerdes JS. Diagnosis and management of bacterial infections in the neonate. Pediatr Clin North Am 2004; 51: 939–959, viii–ix.
   PubMed Web of Science ®Google Scholar
• Brilli RJ, Goldstein B. Pediatric sepsis definitions: Past, present, and future. Pediatr Crit Care Med 2005; 6: S6–S8.
   PubMedGoogle Scholar
• Pearson HA. Neonatal Hematology: A Historical Overview. New York: Cambridge University Press, p. 452, 2005.
   Google Scholar
• Fleer A, Gerards LJ, Verhoef J. Host defence to bacterial infection in the neonate. J Hosp Infect 1988; 11(Suppl A): 320–327.
   Google Scholar
• al-Mulla ZS, Christensen RD. Neutropenia in the neonate. Clin Perinatol 1995; 22: 711–739.
   PubMed Web of Science ®Google Scholar
• Baley JE, Stork EK, Warkentin PI, Shurin SB. Neonatal neutropenia. Clinical manifestations, cause, and outcome. Am J Dis Child 1988; 142: 1161–1166.
   PubMedGoogle Scholar
• Maheshwari A, Christensen RD, Calhoun DA. Immune-mediated neutropenia in the neonate. Acta Paediatr Suppl 2002; 91: 98–103.
   PubMedGoogle Scholar
• Gessler P, Luders R, Konig S, Neonatal neutropenia in low birthweight premature infants. Am J Perinatol 1995; 12: 34–38.
   PubMed Web of Science ®Google Scholar
• Levy O. Innate immunity of the newborn: Basic mechanisms and clinical correlates. Nat Rev Immunol 2007; 7: 379–390.
   PubMed Web of Science ®Google Scholar
• Stiehm ER. Fetal defense mechanisms. Am J Dis Child 1975; 129: 438–443.
   PubMedGoogle Scholar
• Miller ME, Stiehm ER. Phagocytic, opsonic and immunoglobulin studies in newborns. Calif Med 1973; 119: 43–63.
   PubMedGoogle Scholar
• Schlegel RJ, Bellanti JA. Leucocyte G.-6.-P.D. deficiency and bactericidal activity. Lancet 1970; 1: 677–678.
   Google Scholar
• Carr R. Neutrophil production and function in newborn infants. Br J Haematol 2000; 110: 18–28.
   PubMed Web of Science ®Google Scholar
• Anderson DC, Freeman KL, Heerdt B, Abnormal stimulated adherence of neonatal granulocytes: Impaired induction of surface Mac-1 by chemotactic factors or secretagogues. Blood 1987; 70: 740–750.
   PubMedGoogle Scholar
• Rider ED, Christensen RD, Hall DC, Rothstein G. Myeloperoxidase deficiency in neutrophils of neonates. J Pediatr 1988; 112: 648–651.
   Google Scholar
• Dzierzak E, Speck NA. Of lineage and legacy: The development of mammalian hematopoietic stem cells. Nat Immunol 2008; 9: 129–136.
   PubMedGoogle Scholar
• Palis J. Ontogeny of erythropoiesis. Curr Opin Hematol 2008; 15: 155–161.
   PubMedGoogle Scholar
• Migliaccio G, Migliaccio AR, Petti S, Human embryonic hemopoiesis. Kinetics of progenitors and precursors underlying the yolk sac—Liver transition. J Clin Invest 1986; 78: 51–60.
   PubMed Web of Science ®Google Scholar
• Friedman AD. Transcriptional control of granulocyte and monocyte development. Oncogene 2007; 26: 6816–6828.
   PubMed Web of Science ®Google Scholar
• Kondo M, Wagers AJ, Manz MG, Biology of hematopoietic stem cells and progenitors: Implications for clinical application. Annu Rev Immunol 2003; 21: 759–806.
   PubMed Web of Science ®Google Scholar
• Iwasaki H, Akashi K. Myeloid lineage commitment from the hematopoietic stem cell. Immunity 2007; 26: 726–740.
   PubMed Web of Science ®Google Scholar
• Theilgaard-Monch K, Jacobsen LC, Borup R, The transcriptional program of terminal granulocytic differentiation. Blood 2005; 105: 1785–1796.
   Google Scholar
• Theilgaard-Monch K, Porse BT, Borregaard N. Systems biology of neutrophil differentiation and immune response. Curr Opin Immunol 2006; 18: 54–60.
   Google Scholar
• Yamanaka R, Barlow C, Lekstrom-Himes J, Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. Proc Natl Acad Sci U S A 1997; 94: 13187–13192.
   PubMed Web of Science ®Google Scholar
• Radomska HS, Huettner CS, Zhang P, CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol Cell Biol 1998; 18: 4301–4314.
   PubMed Web of Science ®Google Scholar
• Koschmieder S, Halmos B, Levantini E, Tenen DG. Dysregulation of the C/EBPalpha differentiation pathway in human cancer. J Clin Oncol 2009; 27: 619–628.
   PubMed Web of Science ®Google Scholar
• Zhang DE, Zhang P, Wang ND, Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc Natl Acad Sci U S A 1997; 94: 569–574.
   PubMed Web of Science ®Google Scholar
• Zhang P, Iwasaki-Arai J, Iwasaki H, Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. Immunity 2004; 21: 853–863.
   PubMedGoogle Scholar
• Hirai H, Zhang P, Dayaram T, C/EBPbeta is required for ‘emergency’ granulopoiesis. Nat Immunol 2006; 7: 732–739.
   PubMed Web of Science ®Google Scholar
• Kincade PW. Supplying the demand for granulocytes. Nat Immunol 2006; 7: 701–702.
   Google Scholar
• Metcalf D. Control of granulocytes and macrophages: Molecular, cellular, and clinical aspects. Science 1991; 254: 529–533.
   PubMed Web of Science ®Google Scholar
• Panopoulos AD, Watowich SS. Granulocyte colony-stimulating factor: Molecular mechanisms of action during steady state and ‘emergency’ hematopoiesis. Cytokine 2008; 42: 277–288.
   PubMed Web of Science ®Google Scholar
• Nicola NA, Metcalf D. Binding of 125I-labeled granulocyte colony-stimulating factor to normal murine hemopoietic cells. J Cell Physiol 1985; 124: 313–321.
   PubMed Web of Science ®Google Scholar
• Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood 1991; 78: 2791–2808.
   PubMed Web of Science ®Google Scholar
• Avalos BR. Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 1996; 88: 761–777.
   PubMed Web of Science ®Google Scholar
• Wang D, Paz-Priel I, Friedman AD. NF-kappa B p50 regulates C/EBP alpha expression and inflammatory cytokine-induced neutrophil production. J Immunol 2009; 182: 5757–5762.
   PubMed Web of Science ®Google Scholar
• Lien E, Means TK, Heine H, Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 2000; 105: 497–504.
   PubMed Web of Science ®Google Scholar
• Yan SR, Byers DM, Bortolussi R. Role of protein tyrosine kinase p53/56lyn in diminished lipopolysaccharide priming of formylmethionylleucyl-phenylalanine-induced superoxide production in human newborn neutrophils. Infect Immun 2004; 72: 6455–6462.
   PubMed Web of Science ®Google Scholar
• Rashmi R, Bode BP, Panesar N, Siglec-9 and SHP-1 are differentially expressed in neonatal and adult neutrophils. Pediatr Res 2009; 66: 266–271.
   PubMed Web of Science ®Google Scholar
• Marodi L. Deficient interferon-gamma receptor-mediated signaling in neonatal macrophages. Acta Paediatr Suppl 2002; 91: 117–119.
   Google Scholar
• Marodi L, Goda K, Palicz A, Szabo G. Cytokine receptor signalling in neonatal macrophages: Defective STAT-1 phosphorylation in response to stimulation with IFN-gamma. Clin Exp Immunol 2001; 126: 456–460.
   Google Scholar
• Cartwright GE, Athens JW, Wintrobe MM. The kinetics of granulopoiesis in normal man. Blood 1964; 24: 780–803.
   PubMed Web of Science ®Google Scholar
• von Vietinghoff S, Ley K. Homeostatic regulation of blood neutrophil counts. J Immunol 2008; 181: 5183–5188.
   PubMed Web of Science ®Google Scholar
• Semerad CL, Liu F, Gregory AD, G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood. Immunity 2002; 17:413–423.
   PubMed Web of Science ®Google Scholar
• Terashima T, Wiggs B, English D, Polymorphonuclear leukocyte transit times in bone marrow during streptococcal pneumonia. Am J Physiol 1996; 271: L587–L592.
   PubMed Web of Science ®Google Scholar
• Carr R, Modi N. Haemopoietic colony stimulating factors for preterm neonates. Arch Dis Child Fetal Neonatal Ed 1997; 76: F128–F133.
   Google Scholar
• Ueda Y, Kondo M, Kelsoe G. Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J Exp Med 2005; 201: 1771–1780.
   PubMed Web of Science ®Google Scholar
• Watt FM, Hogan BL. Out of Eden: Stem cells and their niches. Science 2000; 287: 1427–1430.
   PubMed Web of Science ®Google Scholar
• Moore KA, Lemischka IR. Stem cells and their niches. Science 2006; 311: 1880–1885.
   PubMed Web of Science ®Google Scholar
• Levesque JP, Winkler IG, Hendy J, Hematopoietic progenitor cell mobilization results in hypoxia with increased hypoxia-inducible transcription factor-1 alpha and vascular endothelial growth factor A in bone marrow. Stem Cells 2007; 25: 1954–1965.
   PubMed Web of Science ®Google Scholar
• Bhattacharya D, Czechowicz A, Ooi AG, Niche recycling through division-independent egress of hematopoietic stem cells. J Exp Med 2009; 206: 2837–2850.
   PubMedGoogle Scholar
• Adams GB, Scadden DT. The hematopoietic stem cell in its place. Nat Immunol 2006; 7: 333–337.
   PubMed Web of Science ®Google Scholar
• Okada S, Nakauchi H, Nagayoshi K, In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells. Blood 1992; 80: 3044–3050.
   PubMed Web of Science ®Google Scholar
• Osawa M, Nakamura K, Nishi N, In vivo self-renewal of c-Kit+ Sca-1+ Lin(low/-) hemopoietic stem cells. J Immunol 1996; 156: 3207–3214.
   PubMed Web of Science ®Google Scholar
• Zhang P, Nelson S, Bagby GJ, The lineage-c-Kit+ Sca-1+ cell response to Escherichia coli bacteremia in Balb/c mice. Stem Cells 2008; 26: 1778–1786.
   Google Scholar
• Chang HH, Hemberg M, Barahona M, Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature 2008; 453: 544–547.
   PubMed Web of Science ®Google Scholar
• Zhang P, Welsh DA, Siggins RW 2nd, Acute alcohol intoxication inhibits the lineage-c-kit +Sca-1+ cell response to Escherichia coli bacteremia. J Immunol 2009; 182: 1568–1576.
   PubMedGoogle Scholar
• Essers MA, Offner S, Blanco-Bose WE, IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 2009; 458: 904–908.
   PubMed Web of Science ®Google Scholar
• Lothian C, Dahlgren C, Lagercrantz H, Lundahl J. Different expression and mobilisation of the complement regulatory proteins CD35, CD55 and CD59 in neonatal and adult neutrophils. Biol Neonate 1997; 72: 15–21.
   Google Scholar
• Rudolph AM, Barnett HL, Einhorn AH. Pediatrics. New York: Appleton-Century-Crofts, 1977.
   Google Scholar
• Manroe BL, Weinberg AG, Rosenfeld CR, Browne R. The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr 1979; 95: 89–98.
   PubMed Web of Science ®Google Scholar
• Mouzinho A, Rosenfeld CR, Sanchez PJ, Risser R. Revised reference ranges for circulating neutrophils in very-low-birth-weight neonates. Pediatrics 1994; 94: 76–82.
   PubMed Web of Science ®Google Scholar
• Christensen RD, Calhoun DA, Rimsza LM. A practical approach to evaluating and treating neutropenia in the neonatal intensive care unit. Clin Perinatol 2000; 27: 577–601.
   PubMed Web of Science ®Google Scholar
• Schmutz N, Henry E, Jopling J, Christensen RD. Expected ranges for blood neutrophil concentrations of neonates: The Manroe and Mouzinho charts revisited. J Perinatol 2008; 28: 275–281.
   PubMed Web of Science ®Google Scholar
• Erdman SH, Christensen RD, Bradley PP, Rothstein G. Supply and release of storage neutrophils. A developmental study. Biol Neonate 1982; 41: 132–137.
   Google Scholar
• Ohls RK, Li Y, Abdel-Mageed A, Neutrophil pool sizes and granulocyte colony-stimulating factor production in human mid-trimester fetuses. Pediatr Res 1995; 37: 806–811.
   PubMed Web of Science ®Google Scholar
• Rosse C, Kraemer MJ, Dillon TL, Bone marrow cell populations of normal infants: The predominance of lymphocytes. J Lab Clin Med 1977; 89: 1225–1240.
   Google Scholar
• Christensen RD. Hematopoiesis in the fetus and neonate. Pediatr Res 1989; 26: 531–535.
   Google Scholar
• Christensen RD, Harper TE, Rothstein G. Granulocyte-macrophage progenitor cells in term and preterm neonates. J Pediatr 1986; 109: 1047–1051.
   Google Scholar
• Forster-Waldl E, Sadeghi K, Tamandl D, Monocyte toll-like receptor 4 expression and LPS-induced cytokine production increase during gestational aging. Pediatr Res 2005; 58: 121–124.
   PubMed Web of Science ®Google Scholar
• Yan SR, Qing G, Byers DM, Role of MyD88 in diminished tumor necrosis factor alpha production by newborn mononuclear cells in response to lipopolysaccharide. Infect Immun 2004; 72: 1223–1229.
   PubMed Web of Science ®Google Scholar
• Al-Hertani W, Yan SR, Byers DM, Bortolussi R. Human newborn polymorphonuclear neutrophils exhibit decreased levels of MyD88 and attenuated p38 phosphorylation in response to lipopolysaccharide. Clin Invest Med 2007; 30: E44–E53.
   PubMedGoogle Scholar
• Sadeghi K, Berger A, Langgartner M, Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling. J Infect Dis 2007; 195: 296–302.
   PubMed Web of Science ®Google Scholar
• Levy O, Coughlin M, Cronstein BN, The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn. J Immunol 2006; 177: 1956–1966.
   PubMed Web of Science ®Google Scholar
• Eigler A, Siegmund B, Emmerich U, Anti-inflammatory activities of cAMP-elevating agents: Enhancement of IL-10 synthesis and concurrent suppression of TNF production. J Leukoc Biol 1998; 63: 101–107.
   PubMed Web of Science ®Google Scholar
• Conti M, Richter W, Mehats C, Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling. J Biol Chem 2003; 278:5493–5496.
   PubMed Web of Science ®Google Scholar
• Kunkel SL, Spengler M, May MA, Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem 1988; 263:5380–5384.
   PubMed Web of Science ®Google Scholar
• Ley K, Zakrzewicz A, Hanski C, Sialylated O-glycans and L-selectin sequentially mediate myeloid cell rolling in vivo. Blood 1995; 85: 3727–3735.
   Google Scholar
• Kim SK, Keeney SE, Alpard SK, Schmalstieg FC. Comparison of L-selectin and CD11b on neutrophils of adults and neonates during the first month of life. Pediatr Res 2003; 53: 132–136.
   PubMedGoogle Scholar
• Anderson DC, Abbassi O, Kishimoto TK, Diminished lectin-, epidermal growth factor-, complement binding domain-cell adhesion molecule-1 on neonatal neutrophils underlies their impaired CD18-independent adhesion to endothelial cells in vitro. J Immunol 1991; 146: 3372–3379.
   Web of Science ®Google Scholar
• Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins. Cell 1991; 65: 859–873.
   PubMed Web of Science ®Google Scholar
• Von Andrian UH, Hansell P, Chambers JD, L-selectin function is required for beta 2-integrin-mediated neutrophil adhesion at physiological shear rates in vivo. Am J Physiol 1992; 263: H1034–H1044.
   PubMed Web of Science ®Google Scholar
• Anderson DC, Miller LJ, Schmalstieg FC, Contributions of the Mac-1 glycoprotein family to adherence-dependent granulocyte functions: Structure-function assessments employing subunit-specific monoclonal antibodies. J Immunol 1986; 137: 15–27.
   PubMed Web of Science ®Google Scholar
• Anderson DC, Rothlein R, Marlin SD, Impaired transendothelial migration by neonatal neutrophils: Abnormalities of Mac-1 (CD11b/CD18)-dependent adherence reactions. Blood 1990; 76: 2613–2621.
   Google Scholar
• McEvoy LT, Zakem-Cloud H, Tosi MF. Total cell content of CR3 (CD11b/CD18) and LFA-1 (CD11a/CD18) in neonatal neutrophils: Relationship to gestational age. Blood 1996; 87: 3929–3933.
   Google Scholar
• Abughali N, Berger M, Tosi MF. Deficient total cell content of CR3 (CD11b) in neonatal neutrophils. Blood 1994; 83: 1086–1092.
   Google Scholar
• Eisenfeld L, Krause PJ, Herson V, Longitudinal study of neutrophil adherence and motility. J Pediatr 1990; 117: 926–929.
   Google Scholar
• Anderson DC, Hughes BJ, Smith CW. Abnormal mobility of neonatal polymorphonuclear leukocytes. Relationship to impaired redistribution of surface adhesion sites by chemotactic factor or colchicine. J Clin Invest 1981; 68:863–874.
   PubMed Web of Science ®Google Scholar
• Weinberger B, Laskin DL, Mariano TM, Mechanisms underlying reduced responsiveness of neonatal neutrophils to distinct chemoattractants. J Leukoc Biol 2001; 70: 969–976.
   Google Scholar
• Howard TH, Meyer WH. Chemotactic peptide modulation of actin assembly and locomotion in neutrophils. J Cell Biol 1984; 98: 1265–1271.
   PubMed Web of Science ®Google Scholar
• Zhang P, Spitzer JA. Acute ethanol administration modulates leukocyte actin polymerization in endotoxic rats. Alcohol Clin Exp Res 1997; 21: 779–783.
   Google Scholar
• Hilmo A, Howard TH. F-actin content of neonate and adult neutrophils. Blood 1987; 69: 945–949.
   Google Scholar
• Harris MC, Shalit M, Southwick FS. Diminished actin polymerization by neutrophils from newborn infants. Pediatr Res 1993; 33: 27–31.
   Google Scholar
• Miller ME. Phagocyte function in the neonate: Selected aspects. Pediatrics 1979; 64: 709–712.
   Google Scholar
• Falconer AE, Carr R, Edwards SW. Impaired neutrophil phagocytosis in preterm neonates: Lack of correlation with expression of immunoglobulin or complement receptors. Biol Neonate 1995; 68: 264–269.
   PubMedGoogle Scholar
• Al-Hadithy H, Addison IE, Goldstone AH, Defective neutrophil function in low-birth-weight, premature infants. J Clin Pathol 1981; 34: 366–370.
   Google Scholar
• Quie PG, Mills EL. Bactericidal and metabolic function of polymorphonuclear leukocytes. Pediatrics 1979; 64: 719–721.
   Google Scholar
• Shigeoka AO, Santos JI, Hill HR. Functional analysis of neutrophil granulocytes from healthy, infected, and stressed neonates. J Pediatr 1979; 95: 454–460.
   PubMedGoogle Scholar
• Kallman J, Schollin J, Schalen C, Impaired phagocytosis and opsonisation towards group B streptococci in preterm neonates. Arch Dis Child Fetal Neonatal Ed 1998; 78: F46–F50.
   Web of Science ®Google Scholar
• Ambruso DR, Cusack N, Thurman G. NADPH oxidase activity of neutrophil specific granules: Requirements for cytosolic components and evidence of assembly during cell activation. Mol Genet Metab 2004; 81: 313–321.
   Google Scholar
• Chudgar UH, Thurman GW, Ambruso DR. Oxidase activity in cord blood neutrophils: A balance between increased membrane associated cytochrome b558 and deficient cytosolic components. Pediatr Blood Cancer 2005; 45:311–317.
   Google Scholar
• Allgaier B, Shi M, Luo D, Koenig JM. Spontaneous and Fas-mediated apoptosis are diminished in umbilical cord blood neutrophils compared with adult neutrophils. J Leukoc Biol 1998; 64: 331–336.
   Google Scholar
• Hanna N, Vasquez P, Pham P, Mechanisms underlying reduced apoptosis in neonatal neutrophils. Pediatr Res 2005; 57: 56–62.
   PubMed Web of Science ®Google Scholar
• Luo D, Schowengerdt KO Jr, Stegner JJ, Decreased functional caspase-3 expression in umbilical cord blood neutrophils is linked to delayed apoptosis. Pediatr Res 2003; 53: 859–864.
   Google Scholar
• Suen Y, Lee SM, Qian J, Dysregulation of lymphokine production in the neonate and its impact on neonatal cell mediated immunity. Vaccine 1998; 16: 1369–1377.
   PubMed Web of Science ®Google Scholar
• Brinkmann V, Reichard U, Goosmann C, Neutrophil extracellular traps kill bacteria. Science 2004; 303: 1532–1535.
   PubMed Web of Science ®Google Scholar
• Fuchs TA, Abed U, Goosmann C, Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 2007; 176: 231–241.
   PubMed Web of Science ®Google Scholar
• Yost CC, Cody MJ, Harris ES, Impaired neutrophil extracellular trap (NET) formation: A novel innate immune deficiency of human neonates. Blood 2009; 113: 6419–6427.
   PubMed Web of Science ®Google Scholar
• Schrag SJ, Stoll BJ. Early-onset neonatal sepsis in the era of widespread intrapartum chemoprophylaxis. Pediatr Infect Dis J 2006; 25: 939–940.
   PubMedGoogle Scholar
• Cordero L, Sananes M, Ayers LW. Bloodstream infections in a neonatal intensive-care unit: 12 years’ experience with an antibiotic control program. Infect Control Hosp Epidemiol 1999; 20: 242–246.
   Google Scholar
• Wynn JL, Neu J, Moldawer LL, Levy O. Potential of immunomodulatory agents for prevention and treatment of neonatal sepsis. J Perinatol 2009; 29: 79–88.
   PubMed Web of Science ®Google Scholar
• Metcalf D. The granulocyte-macrophage colony stimulating factors. Cell 1985; 43: 5–6.
   PubMedGoogle Scholar
• Molloy EJ, O’Neill AJ, Grantham JJ, Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function. Pediatr Res 2005; 57: 806–812.
   Google Scholar
• Napolitano LM. Immune stimulation in sepsis: To be or not to be? Chest 2005; 127: 1882–1885.
   Google Scholar
• Roberts RL, Szelc CM, Scates SM, Neutropenia in an extremely premature infant treated with recombinant human granulocyte colony-stimulating factor. Am J Dis Child 1991; 145: 808–812.
   PubMedGoogle Scholar
• Cairo MS, Worcester CC, Rucker RW, Randomized trial of granulocyte transfusions versus intravenous immune globulin therapy for neonatal neutropenia and sepsis. J Pediatr 1992; 120: 281–285.
   Google Scholar
• Schibler KR, Liechty KW, White WL, Christensen RD. Production of granulocyte colony-stimulating factor in vitro by monocytes from preterm and term neonates. Blood 1993; 82: 2478–2484.
   Google Scholar
• Carr R, Modi N, Dore C. G-CSF and GM-CSF for treating or preventing neonatal infections. Cochrane Database Syst Rev 2003; (3): CD003066.
   Google Scholar
• Schibler KR, Osborne KA, Leung LY, A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis. Pediatrics 1998; 102: 6–13.
   PubMed Web of Science ®Google Scholar
• Kuhn P, Messer J, Paupe A, A multicenter, randomized, placebo-controlled trial of prophylactic recombinant granulocyte-colony stimulating factor in preterm neonates with neutropenia. J Pediatr 2009; 155: 324–330. e1.
   PubMedGoogle Scholar
• Carr R, Modi N, Dore CJ, A randomized, controlled trial of prophylactic granulocyte-macrophage colony-stimulating factor in human newborns less than 32 weeks gestation. Pediatrics 1999; 103: 796–802.
   Google Scholar
• Kocherlakota P, La Gamma EF. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia. Pediatrics 1998; 102: 1107–1111.
   PubMed Web of Science ®Google Scholar
• Miura E, Procianoy RS, Bittar C, A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis. Pediatrics 2001; 107: 30–35.
   PubMed Web of Science ®Google Scholar
• Bernstein HM, Calhoun DA, Christensen RD. Use of myeloid colony-stimulating factors in neonates with septicemia. Curr Opin Pediatr 2002; 14: 91–94.
   Google Scholar
• Carr R, Brocklehurst P, Dore CJ, Modi N. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): A single-blind, multicentre, randomised controlled trial. Lancet 2009; 373:226–233.
   PubMed Web of Science ®Google Scholar
• Healy CM, Baker CJ. Prospects for prevention of childhood infections by maternal immunization. Curr Opin Infect Dis 2006; 19: 271–276.
   PubMed Web of Science ®Google Scholar
• Munoz FM, Englund JA. A step ahead. Infant protection through maternal immunization. Pediatr Clin North Am 2000; 47: 449–463.
   PubMed Web of Science ®Google Scholar
• Healy CM, Baker CJ. Maternal immunization. Pediatr Infect Dis J 2007; 26: 945–948.
   Web of Science ®Google Scholar
• Baker CJ, Rench MA, Edwards MS, Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. N Engl J Med 1988; 319: 1180–1185.
   PubMed Web of Science ®Google Scholar
• Baker CJ, Edwards MS. Group B streptococcal conjugate vaccines. Arch Dis Child 2003; 88: 375–378.
   PubMed Web of Science ®Google Scholar
• von Muralt G, Sidiropoulos D. Prenatal and postnatal prophylaxis of infections in preterm neonates. Pediatr Infect Dis J 1988; 7: S72–S78.
   Google Scholar
• Baker CJ, Kasper DL. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 1976; 294: 753–756.
   PubMed Web of Science ®Google Scholar
• Shigeoka AO, Hall RT, Hill HR. Blood-transfusion in group-B streptococcal sepsis. Lancet 1978; 1: 636–638.
   PubMed Web of Science ®Google Scholar
• Sidiropoulos D, Bohme U, von Muralt G, Immunoglobulin substitution in the treatment of neonatal septicemia. Schweiz Med Wochenschr 1981; 111:1649–1655.
   PubMedGoogle Scholar
• Haque KN, Zaidi MH, Bahakim H. IgM-enriched intravenous immunoglobulin therapy in neonatal sepsis. Am J Dis Child 1988; 142: 1293–1296.
   PubMedGoogle Scholar
• Haque KN, Remo C, Bahakim H. Comparison of two types of intravenous immunoglobulins in the treatment of neonatal sepsis. Clin Exp Immunol 1995; 101: 328–333.
   Google Scholar
• Dellinger RP, Levy MM, Carlet JM, Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296–327.
   PubMed Web of Science ®Google Scholar
• Baker CJ, Melish ME, Hall RT, Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. The Multicenter Group for the Study of Immune Globulin in Neonates. N Engl J Med 1992; 327:213–219.
   PubMed Web of Science ®Google Scholar
• Christensen RD, Brown MS, Hall DC, Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis. J Pediatr 1991; 118:606–614.
   PubMed Web of Science ®Google Scholar
• Jenson HB, Pollock BH. Meta-analyses of the effectiveness of intravenous immune globulin for prevention and treatment of neonatal sepsis. Pediatrics 1997; 99: E2.
   Google Scholar
• Krause PJ, Herson VC, Eisenfeld L, Johnson GM. Enhancement of neutrophil function for treatment of neonatal infections. Pediatr Infect Dis J 1989; 8:382–389.
   PubMed Web of Science ®Google Scholar
• Lewis DB, Gern JE, Hill HR, Newborn immunology: Relevance to the clinician. Curr Probl Pediatr Adolesc Health Care 2006; 36: 189–204.
   Google Scholar
• Laurenti F, Ferro R, Isacchi G, Polymorphonuclear leukocyte transfusion for the treatment of sepsis in the newborn infant. J Pediatr 1981; 98: 118–123.
   PubMed Web of Science ®Google Scholar
• Christensen RD, Rothstein G, Anstall HB, Bybee B. Granulocyte transfusions in neonates with bacterial infection, neutropenia, and depletion of mature marrow neutrophils. Pediatrics 1982; 70: 1–6.
   PubMed Web of Science ®Google Scholar
• Mohan P, Brocklehurst P. Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropaenia. Cochrane Database Syst. Rev. 2003; (4): CD003956.
   Google Scholar
• Sullivan GW, Carper HT, Novick WJ Jr, Mandell GL. Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline. Infect Immun 1988; 56: 1722–1729.
   PubMed Web of Science ®Google Scholar
• Coccia MT, Waxman K, Soliman MH, Pentoxifylline improves survival following hemorrhagic shock. Crit Care Med 1989; 17: 36–38.
   Google Scholar
• Zeni F, Pain P, Vindimian M, Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: Results from a double-blind, randomized, placebo-controlled study. Crit Care Med 1996; 24: 207–214.
   PubMed Web of Science ®Google Scholar
• Lauterbach R, Zembala M. Pentoxifylline reduces plasma tumour necrosis factor-alpha concentration in premature infants with sepsis. Eur J Pediatr 1996; 155: 404–409.
   PubMed Web of Science ®Google Scholar
• Lauterbach R, Pawlik D, Kowalczyk D, Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: A placebo-controlled, double-blind trial. Crit Care Med 1999; 27:807–814.
   PubMed Web of Science ®Google Scholar
• Krause PJ, Kristie J, Wang WP, Pentoxifylline enhancement of defective neutrophil function and host defense in neonatal mice. Am J Pathol 1987; 129: 217–222.
   Google Scholar
• Krause PJ, Maderazo EG, Contrino J, Modulation of neonatal neutrophil function by pentoxifylline. Pediatr Res 1991; 29: 123–127.
   Google Scholar
• Ruef P, Poeschl JM, Simon C, Effect of activators and the phosphodiesterase inhibitors pentoxifylline and enoximone on the deformability of neutrophils in neonates and adults. Acta Paediatr 2004; 93: 1288–1293.
   PubMed Web of Science ®Google Scholar
• Haque K, Mohan P. Pentoxifylline for neonatal sepsis. Cochrane Database Syst. Rev. 2003; (4): CD004205.
   Google Scholar
• Zimmerman JJ. Appraising the potential of pentoxifylline in septic premies. Crit Care Med 1999; 27: 695–697.
   PubMed Web of Science ®Google Scholar
• Travadi J, Patole S, Charles A, Pentoxifylline reduces the incidence and severity of necrotizing enterocolitis in a neonatal rat model. Pediatr Res 2006; 60: 185–189.
   PubMed Web of Science ®Google Scholar